A new complex medical diagnosis may do more than reshape a patient’s treatment plan. It may also influence which health insurance system that patient chooses, according to a large cohort study of more than 1 million Medicare Advantage beneficiaries published in JAMA Health Forum. The study found that beneficiaries who developed a new complex medical condition were more likely to disenroll from Medicare Advantage, with the largest movement occurring toward traditional Medicare. The likelihood of leaving increased as the number of newly acquired conditions rose, suggesting that the growing demands of complex illness may expose important differences between the two forms of Medicare coverage.
Medicare Advantage, also known as Medicare Part C, is delivered through private insurance plans that receive payments from the federal government to provide Medicare-covered services. These plans commonly use provider networks, prior authorization requirements, and coordinated-care structures to manage spending and organize treatment. Traditional Medicare, by contrast, generally allows beneficiaries to seek care from any clinician or facility that accepts Medicare, although many people purchase supplemental Medigap insurance to help cover deductibles and coinsurance. For patients whose health care becomes more complicated, the practical consequences of these structural differences can become increasingly significant.
The study focused on beneficiaries who developed new complex medical conditions during the observation period. Such conditions can require care from multiple specialists, repeated hospital visits, advanced diagnostic testing, long-term medication management, or coordination across several health systems. A new diagnosis may therefore increase not only the volume of medical care a person needs but also the importance of having unrestricted access to clinicians and facilities. The researchers examined whether these changes in health status were associated with a subsequent decision to leave Medicare Advantage and identified the type of coverage beneficiaries selected after disenrollment.
The pattern was consistent: developing a new complex condition was associated with a greater probability of disenrollment, particularly into traditional Medicare. The association became stronger as beneficiaries accumulated additional new conditions. This dose-response pattern is important in epidemiologic research because it indicates that the relationship was not limited to a single diagnosis or an isolated group of patients. Instead, the findings suggest that increasing medical complexity may correspond with increasing pressure to reassess the suitability of a health plan’s networks, administrative rules, cost-sharing arrangements, and access to specialized services.
The study does not establish that a diagnosis directly caused a beneficiary to leave Medicare Advantage. Because the research used observational cohort data, the investigators could identify an association but could not fully rule out other explanations. Beneficiaries who become seriously ill may experience changes in income, caregiving support, residence, physician recommendations, or access to local specialists at the same time they develop new conditions. They may also be more likely to encounter plan-related barriers or to compare coverage options during periods of intensive medical treatment. Even so, the size of the cohort and the consistent increase in disenrollment associated with a growing number of conditions provide evidence that illness complexity is an important factor in insurance-market behavior.
The researchers also found that disenrollment was higher among beneficiaries living in states with Medigap guaranteed-issue and community-rating protections. Medigap policies are private supplemental plans that help pay some of the costs left by traditional Medicare. In many circumstances, insurers can consider an applicant’s health status when determining eligibility or premiums, potentially making supplemental coverage difficult or expensive to obtain after a serious diagnosis. Guaranteed-issue protections can require insurers to offer Medigap coverage to eligible individuals in specified circumstances, while community-rating rules restrict the extent to which premiums can vary according to health status. Together, these policies may reduce the financial and administrative risks of switching from Medicare Advantage to traditional Medicare.
That state-level finding points to the role of insurance regulation in shaping the choices available to older adults with complex health needs. A beneficiary might prefer the broader provider access associated with traditional Medicare but hesitate to switch if supplemental coverage is unavailable or unaffordable. Without Medigap, traditional Medicare beneficiaries may face substantial cost sharing, including deductibles and coinsurance that can accumulate during repeated hospitalizations, specialist visits, or outpatient treatments. In states where consumer protections make Medigap more accessible, beneficiaries who become medically complex may have a clearer path to traditional Medicare, potentially explaining the higher disenrollment observed in those jurisdictions.
The results also raise questions about how Medicare Advantage plans should be evaluated. Medicare Advantage has expanded rapidly because it can offer predictable costs, additional benefits, and coordinated management of care. For many beneficiaries, these features may be attractive or clinically useful. Yet the study suggests that enrollment stability may vary according to health status. If beneficiaries are more likely to leave after developing serious or multiple conditions, plans could experience changes in their populations that affect risk adjustment, provider contracting, and care-management strategies. The finding may also prompt policymakers to examine whether network adequacy, prior authorization, continuity of care, and access to high-complexity specialists remain sufficient when enrollees’ medical needs change.
For patients and families, the findings underscore that insurance decisions are not static. Coverage that appears satisfactory while a person is relatively healthy may feel different after the onset of cancer, heart failure, kidney disease, severe respiratory illness, or another condition requiring sustained, multidisciplinary care. The study’s central message is not that one Medicare option is universally better than the other, but that the ability to move between options may become especially important when illness becomes complex. By linking new diagnoses with subsequent disenrollment—and by showing that state insurance protections may influence that transition—the research highlights a hidden dimension of aging and chronic disease: medical events can alter not only health trajectories, but also the architecture of coverage through which care is received.
Subject of Research: The association between newly developed complex medical conditions, Medicare Advantage disenrollment, and transitions to traditional Medicare among Medicare beneficiaries.
Web References: https://doi.org/10.1001/jamahealthforum.2026.2843
References: Meiselbach MK et al. Study published in JAMA Health Forum. DOI: 10.1001/jamahealthforum.2026.2843
Keywords: Medicare Advantage, traditional Medicare, health insurance, Medigap, guaranteed issue, community rating, disenrollment, complex medical conditions, older adults, cohort study, health policy, insurance regulation
Tags: complex medical diagnoses impacteffects of complex illnesses on healthcare choicesenrollment disenrollment factorshealthcare management for complex conditionsimpact of complex diagnoses on insurance coverageMedicare Advantage enrollment decisionsMedigap supplemental insurance coveragepatient decision-making in Medicareprivate insurance plans for seniorsprovider networks and care coordinationsenior healthcare policy and coverage optionsTraditional Medicare vs Medicare Advantage
